Merck to Cut 1,800 Jobs and Add 960 in Chronic Care
The particular areas where sales jobs will be thinned is primary care, disease-focused endocrinology and hospital chronic care.
The Home of the Life Sciences Industry
Explore Latest News
$710M Gamble Fails as Celgene Terminates Two Phase III Trials
Celgene is scrapping a late-stage Crohn's disease drug it acquired in a $710M deal three years ago following an interim data analysis.
- 4 Large Cap Pharmas That Could Post Huge Earnings
- Rumors Swirl of a Smith & Nephew Takeover with Stryker and Medtronic as Top Buyers
- Gilead's $12B Bet Pays Off in Two Months After the FDA Approves Kite's Revolutionary CAR-T Therapy
- Pfizer Quietly Takes Additional Stake in This Boston Pharma
- Here is the One Biotech Billionaire Investors Love
Employers
Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.